Tagala, Crisanto C.
HRN: 01-93-16 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
CEFTRIAXONE 1G (VIAL)
05/23/2022
05/30/2022
IV
2g
OD
UTI
Waiting Final Action